Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine|May 29, 2004
Who calls for the ambulance: implications for decision support. A descriptive study from a Swedish dispatch centreRolf Karlsten, Per Elowsson
Resuscitation|May 28, 2005
Increased cortical cerebral blood flow with LUCAS; a new device for mechanical chest compressions compared to standard external compressions during experimental cardiopulmonary resuscitationSten Rubertsson, Rolf Karlsten
Scandinavian Journal of Pain|August 30, 2017
The changing face of acute pain servicesAdriana Miclescu, Stephen Butler, Rolf Karlsten
Contemporary Clinical Trials|March 10, 2012
Early phase drug development for treatment of chronic pain--options for clinical trial and program designJarkko Kalliomäki, Frank Miller, Matts Kågedal, et al.
Contemporary Clinical Trials|January 8, 2014
Experiences with an adaptive design for a dose-finding study in patients with osteoarthritisFrank Miller, Marcus Björnsson, Ola Svensson, et al.
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine|February 25, 2011
Feasibility of a computer-assisted feedback system between dispatch centre and ambulancesVeronica Lindström, Rolf Karlsten, Ann-Charlotte Falk, et al.
Pain|January 1, 1994
The NMDA antagonist 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid (CPP) has antinociceptive effect after intrathecal injection in the ratJens D Kristensen, Rolf Karlsten, Torsten Gordh, et al.
Scandinavian Journal of Pain|November 9, 2018
The utility/futility of medications for neuropathic pain - an observational studyStephen Butler, Daniel Eek, Lena Ring, et al.
Resuscitation|July 5, 2011
Poor chest compression quality with mechanical compressions in simulated cardiopulmonary resuscitation: a randomized, cross-over manikin studyHans Blomberg, Rolf Gedeborg, Lars Berglund, et al.
Scandinavian Journal of Pain|July 25, 2025
Topically applied novel TRPV1 receptor antagonist, ACD440 Gel, reduces temperature-evoked pain in patients with peripheral neuropathic pain with sensory hypersensitivity, a randomized, double-blind, placebo-controlled, crossover studyAdriana Miclescu, Rolf Karlsten, Ingrid Lönnstedt, et al.
Pageof 4